[HTML][HTML] Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
[HTML][HTML] Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, SJ Howell… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, SJ Howell… - British Journal of …, 2021 - eprints.ncl.ac.uk
BACKGROUND: Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.
M Harvie, M Pegington, SJ Howell… - British Journal of …, 2021 - europepmc.org
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, SJ Howell, N Bundred… - 2021 - christie.openrepository.com
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, SJ Howell, N Bundred… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, SJ Howell… - British Journal of …, 2022 - research.manchester.ac.uk
BACKGROUND: Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
[PDF][PDF] Harvie, M, Pegington, M, Howell, S, Bundred, N, Foden, P, Adams, J, Graves, LEF, Greystoke, A, Mattson, M, Cutler, R, Williamson, J, Livingstone, K, McMullen …
M Harvie, M Pegington, S Howell, N Bundred, P Foden… - core.ac.uk
BACKGROUND: Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent versus continuous energy restriction during chemotherapy for early breast cancer
M Harvie, M Pegington, S Howell… - British Journal of …, 2021 - researchonline.ljmu.ac.uk
Background: Excess adiposity at diagnosis and weight gain during chemotherapy are
associated with recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with recurrence and chemotherapy toxicity. We assessed the efficacy of …
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer.
M Harvie, M Pegington, SJ Howell… - British Journal of …, 2021 - europepmc.org
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …